Patents
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
06/2003
06/25/2003CN1425439A Medicinal composition with beauty function and its preparing method
06/25/2003CN1425407A External treatment powder for piles
06/25/2003CN1425397A Sight promoting agent
06/25/2003CN1112336C Vital matter and preparing method thereof
06/25/2003CN1112212C Medicine liquid for treating pain of injury
06/25/2003CN1112208C Chinese medicine for treating intraocular hemorrhage
06/25/2003CN1112206C Bone fracture setting medicine powder
06/25/2003CN1112188C Nasal drops
06/25/2003CN1112175C Cosmetic or dermo-pharmaceutical products compatible with cutaneous ecology
06/24/2003US6583181 Antimicrobial quaternary ammonium compositions with reduced ocular irritation
06/24/2003US6583124 For controlled administration of pharmaceutically active agents to patients, wherein formulation is administered as liquids which thicken to form gels upon instillation into the eye
06/24/2003US6583123 Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue
06/24/2003US6582961 Generating disease resistant plants; obtain plant, incubate with vector coding preferential enzymatic polypeptides, transform, recover transformed plants, propagate, monitor plant resistance to disease
06/24/2003US6582734 Antimicrobial composition useful for the treatment of bovine mastitis
06/24/2003US6582733 Composition for the treatment of hepatitis including HCV
06/24/2003US6582731 Mixed with carriers, water and sugar substitute; heating, cooking, cooling, and shaping; teeth cleaning
06/24/2003US6582708 Tooth whitening substance which comprises a high concentration of water, a peroxide, a gelling agent, and carrier materials. The tooth whitening substance will remain stable when stored as a thin layer. The present invention also relates to a
06/24/2003CA2343439C Compositions useful in the treatment of diseases of connective tissues
06/24/2003CA2221011C A coated sodium phosphate bowel cleanser
06/19/2003WO2003050108A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003WO2003050066A1 Functionalized higher diamondoids
06/19/2003WO2003050053A2 Use of an antimicrobial glass ceramic for dental care and oral hygiene
06/19/2003WO2003050051A1 Antimicrobial alkali-silicate glass ceramic and the use thereof
06/19/2003WO2003050044A1 Electrochemically activated water for the treatment of cystitis
06/19/2003WO2003049914A2 Thermoplastic articles exhibiting high surface-available silver
06/19/2003WO2003049805A1 Device for treating headache
06/19/2003WO2003049769A2 Method for reducing acne or improving skin tone
06/19/2003WO2003049750A1 Method for treating infectious conditions of mucosae and muco-cutaneous tissue
06/19/2003WO2003049749A1 Treatment of dairy cattle through use of electrochemically activated, aqueous solutions
06/19/2003WO2003049748A1 Pharmaceutical and foodstuff products comprising deuterium for the treatment of diabetes and methods for production thereof
06/19/2003WO2003049686A2 Stabilization of hypoxia inducible factor (hif) alpha
06/19/2003WO2003049660A1 Oxygen producing device for woundcare
06/19/2003WO2003049593A2 Prevention of flap necrosis in plastic surgery
06/19/2003WO2003028767A3 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions and methods
06/19/2003US20030114504 Compositions and methods for the treatment of cancer
06/19/2003US20030114484 Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
06/19/2003US20030114393 Use of steroidal alkaloids to reverse multidrug resistance
06/19/2003US20030113402 Giving animals drinking water containing a halogen-type microbiocide reduces fecal contamination and thus reduces contamination of meat; may be specific dihalo dialkyl hydantoins or product of water, halogen and sulfamate
06/19/2003US20030113384 Antimicrobial compositions for mastitis control
06/19/2003US20030113382 Causing cyclic GMP to increase in the neoplastic cells and exposing neoplastic cells to cisplatin derivative
06/19/2003US20030113381 Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
06/19/2003US20030113378 Thermoplastic articles exhibiting high surface-available silver
06/19/2003US20030113315 Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
06/19/2003US20030113276 Flexible polybutene strips for preventing gingivitis/whitening of teeth
06/19/2003CA2469889A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003CA2469858A1 Functionalized higher diamondoids
06/19/2003CA2469770A1 Device for treating headache
06/19/2003CA2469000A1 Method for reducing acne or improving skin tone
06/19/2003CA2467689A1 Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
06/19/2003CA2467245A1 Prevention of flap necrosis in plastic surgery
06/18/2003EP1319345A1 The effect of a buffering agent on acidogenesis of plaque
06/18/2003EP1318839A2 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
06/18/2003EP1318821A1 Fluid for haemofiltration
06/18/2003EP1318820A2 Xenon as medicament
06/18/2003EP1318804A1 Iron compositions
06/18/2003EP1318797A1 Volatile anaesthetic with xenon
06/18/2003EP1200317B1 A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids
06/18/2003EP0920623B1 Boron neutron capture therapy using pre-targeting methods
06/18/2003EP0904059B1 Improvement in the taste of active pharmaceutical ingredients
06/18/2003EP0839459B1 Composition containing readily absorbable calcium and process for producing the same
06/18/2003CN1424071A Auxiliary medicine for treating esophagus cancer and processing method thereof
06/18/2003CN1424070A Plaster
06/18/2003CN1424048A Medicine for treating bacillary dysentery and enteritis
06/18/2003CN1424047A Safety quick effective rectal suppository made of glycerin, sodium chloride and water
06/18/2003CN1111425C Plaster for treating hyperosteogeny
06/18/2003CN1111422C Injection for treating piles and its preparing process
06/18/2003CN1111414C Use of magnesium salts or magnesium complex as production of medicines
06/17/2003US6579906 Stability, nontoxic; anthrax
06/17/2003US6579905 Method for the prevention or treatment of hypomagnesemia in pediatric patients and in patients with G-tubes or NG-tubes
06/17/2003US6579899 Composition for treatment of stress
06/17/2003US6579866 Composition and method for modulating nutrient partitioning
06/17/2003US6579544 Blends of vitamins, minerals, carotenoids, flavinoids, glucosamine, chondroitin sulfate, lipoic acid/-A/, coenzyme Q10 and linseed oils for preventing diseases such as degenerative joint disease
06/17/2003US6579541 Oxidative fluorinator compounds as antimicrobials
06/17/2003US6579540 Administering bis/maltolato/oxovanadium for prophylaxis of tisssue injuries or traumas
06/12/2003WO2003048168A2 Trioxane derivatives as antimalaria or anticancer compounds
06/12/2003WO2003048112A1 Aminoacetonitrile derivatives and their use for controlling parasites
06/12/2003WO2003047697A2 Use of an farsenyl protein tranferase inhibitor in combination with other antineoplastic agents for the manufacture of a medicament against cancer
06/12/2003WO2003047633A2 Treatment of angiogenesis disorders using targeted nanoparticles
06/12/2003WO2003047605A1 Products of natural substance of organic iodine content
06/12/2003WO2003047604A1 Use of selenite-containing compounds to be topically or buccally administered
06/12/2003WO2003047603A2 Breathable gas mixtures to change body temperature
06/12/2003WO2003047586A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
06/12/2003WO2003047353A1 Probiotic formulation and method for reduction of pathogenic bacteria
06/12/2003WO2002000192A8 Embolization using carbon coated particles
06/12/2003WO2001073133A9 Compositions and methods for identifying and targeting cancer cells
06/12/2003US20030109486 Methods and therapeutic compositions for utilization of adenosine 5'-triphosphate (ATP) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS)
06/12/2003US20030109417 Administering substance P receptor antagonist selected from the group consisting of L 742694, L 758298, and LY 303241, a non-toxic magnesium compound and a pharmaceutically acceptable vehicle
06/12/2003US20030108625 Administering vanadate suspended in decocted black tea, jasmine tea or Japanese green tea; vanadate suspended in decocted black tea, jasmine tea or Japanese green tea; antidiabetic and hyperglycemic agents; side effect reduction
06/12/2003US20030108624 Treating micro- and macroangiopathic conditions with a bioflavonoid plant extract as antioxidant along with a neovascular controller as an angiogenesis inhibitor; vision defects; wound healing agents; cardiovascular disorders
06/12/2003US20030108621 Use of iodide salt as an aphrodisiac
06/12/2003US20030108620 Prophylactic treatment of secondary injury of tissue traumatic event, surgery, transplant, nonproliferative tissue, burns, using of 3-methylsulfonyl-4-piperidinyl benzoyl)guanidine methanesulfonate or N,N-dimethylamiloride
06/12/2003US20030108619 Synergistic mixture of casein polypeptide to promote calcium absorption and genistein which inhibits bone resorption and promotes osteogenesis; prevent decrease in bone density and onset of osteoporosis
06/12/2003US20030108618 Non-pharmacological method for treating depression, skin disorders, and improving overall health and wellness
06/12/2003US20030108612 Metallic nanoparticles for inhibition of bacterium growth
06/12/2003US20030108608 Thermoplastic articles comprising silver-containing antimicrobials and high amounts of carboxylic acid salts for increased surface-available silver
06/12/2003US20030108591 Mixture of flavonoids, vegetable protein and sterols
06/12/2003US20030108545 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
06/12/2003CA2819733A1 Use of selenite-containing compounds to be topically or buccally administered for treating or preventing sunburn
06/12/2003CA2819731A1 Use of selenite-containing compounds to be topically or buccally administered for treating an insect bite
06/12/2003CA2735287A1 Use of selenite-containing compounds to be topically or buccally administered